J&J paid $785M for an exclusive $2.58B option on Sail Biomedicines' in vivo CAR-T platform — a cell therapy that has never reached a patient. Immune reset without the factory could rewrite immunology economics.
Eos Energy Enterprises won a Golden Dome contract to deploy its Z3 zinc long-duration storage as a prototype, alongside record Q2 revenue and an $807 million backlog.
SambaNova closed a $1B Series F at $11B — seven months after a $1.6B Intel takeover collapsed. The JPMorgan inference win is the real signal.
BMW put two AEON humanoids from Hexagon Robotics to work at Plant Leipzig in June 2026, Europe's first humanoid deployment in car production. Figure 03 is sorting parts at Spartanburg. The operating data says more about the sector than the forecasts do.
The Princeton spinout won a $20M ARPA-E SCALEUP award to build the first U.S. production line of modular HTS magnets, betting fusion's economics hinge on manufacturing, not physics. Eos targets 2030.
SWISSto12's $70M Series C funds washing-machine-sized, 3D-printed geostationary satellites. Seven HummingSat orders form a $500M backlog, revenue hit $140M in 2025, and ESA's ARTES program funds in-orbit validation ahead of first delivery to SES in 2027.
Science Corporation's PRIMA BCI retinal implant received CE mark approval, restoring functional central vision in patients with geographic atrophy due to age-related macular degeneration. First commercial implant expected in Germany September 2026.
The DIU awarded Gallatin AI a JSDT contract to deploy Navigator — an agentic AI-powered logistics planning platform — to US Army Europe and Africa, signaling agentic AI's move from tactical pilots to theatre-level sustainment operations.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
